Takeda SAS

Takeda SAS, established in 1991, is a prominent entity within the Pharmaceuticals and Healthcare sectors. The company focuses on developing and delivering critical biopharmaceutical solutions, with significant efforts in oncology, therapeutic areas, and vaccine research. Operating from a single location, Takeda SAS is dedicated to advancing medical science and providing essential prescription drugs. Its commitment extends to fostering innovation and improving patient outcomes through its specialized product portfolio.

With a workforce ranging from 500-1,000 employees, Takeda SAS manages substantial operations, generating an annual revenue of $144.3M. The company's operational hub is situated in Toronto, Ontario, Canada. This strategic location supports its mission to drive healthcare advancements. For insights into the individuals powering these initiatives, explore Meet Takeda SAS's team. Takeda SAS leverages its expertise to address complex health challenges and contribute to global well-being.

The company's product scope encompasses areas such as medical education and respiratory health, aiming to create a brighter future for people worldwide. Takeda SAS is committed to long-term strategies that ensure the availability of life-saving medicines and innovative treatments. Its online presence at www.takeda.ca serves as a gateway to understanding its comprehensive approach to healthcare and its ongoing contributions to the biopharmaceutical landscape. The company's hashtags indicate a focus on its founding year and market presence.